The incidence of both non-melanoma and melanoma skin cancers has been increasing over the past decades. WHO numbers estimate that between 2 and 3 million non-melanoma skin cancers and 132,000 melanoma skin cancers occur globally each year. One in every three cancers diagnosed is a skin cancer.
In the US alone the estimated numbers of new cases of invasive melanoma are 87,110, resulting in 9,730 deaths in 2017, up 26% on 2009. Numbers from Australia back this mortality rate of 11% and show that incidences are increasing.
Whilst non-melanoma skin cancer is far less dangerous, it still has a mortality rate of 1%.
A conservative estimate, with skin cancer cases increasing at a reduced rate due to better public knowledge and practices, would still see 500,000 individuals dying of the disease over the next decade.
Our aim is to develop SkinVision globally through partnerships with key health care providers and to provide millions more with the ability to track their own skin health, allowing them to attain diagnosis earlier, reducing the annual deaths by half and contributing to our aim of saving 250,000 in the next decade.